APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rheolytic Thrombectomy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rheolytic Thrombectomy Market Outlook and Growth Opportunities 2026

4 July 2026192 pages

Choose your research edition.

Industry ResearchRheolytic Thrombectomy Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheolytic Thrombectomy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Rheolytic Thrombectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheolytic Thrombectomy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheolytic Thrombectomy Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Rheolytic Thrombectomy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rheolytic Thrombectomy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rheolytic Thrombectomy market include Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Group, Medtronic plc, AngioDynamics, Penumbra Inc., Stryker Corporation and Teleflex Incorporated, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Rheolytic Thrombectomy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rheolytic Thrombectomy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rheolytic Thrombectomy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Rheolytic Thrombectomy market.

Rheolytic Thrombectomy Segment by Company

Abbott Laboratories

Koninklijke Philips N.V.

Terumo Corporation

Boston Scientific Group

Medtronic plc

AngioDynamics

Penumbra Inc.

Stryker Corporation

Teleflex Incorporated

Johnson and Johnson

Rheolytic Thrombectomy Segment by Type

Automated Devices

Manual Devices

Rheolytic Thrombectomy Segment by Application

Peripheral Diseases

Coronary Disease

Neural Diseases

Rheolytic Thrombectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rheolytic Thrombectomy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Rheolytic Thrombectomy key companies, revenue, market share, and recent developments.

3. To split the Rheolytic Thrombectomy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Rheolytic Thrombectomy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rheolytic Thrombectomy significant trends, drivers, influence factors in global and regions.

6. To analyze Rheolytic Thrombectomy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheolytic Thrombectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheolytic Thrombectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheolytic Thrombectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rheolytic Thrombectomy industry.

Chapter 3: Detailed analysis of Rheolytic Thrombectomy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Rheolytic Thrombectomy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Rheolytic Thrombectomy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rheolytic Thrombectomy Industry Trends Table 2. Rheolytic Thrombectomy Industry Drivers Table 3. Rheolytic Thrombectomy Industry Opportunities and Challenges Table 4. Rheolytic Thrombectomy Industry Restraints Table 5. Global Rheolytic Thrombectomy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rheolytic Thrombectomy Revenue Share by Company (2021-2026) Table 7. Global Rheolytic Thrombectomy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Rheolytic Thrombectomy Key Company Manufacturing Base & Headquarters Table 9. Global Rheolytic Thrombectomy Company, Product Type & Application Table 10. Global Rheolytic Thrombectomy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Rheolytic Thrombectomy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Automated Devices Table 15. Significant Companies of Manual Devices Table 16. Global Rheolytic Thrombectomy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Rheolytic Thrombectomy Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Rheolytic Thrombectomy Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Rheolytic Thrombectomy Sales Value Share by Type (2021-2026) Table 20. Global Rheolytic Thrombectomy Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Peripheral Diseases Table 22. Significant Companies of Coronary Disease Table 23. Significant Companies of Neural Diseases Table 24. Global Rheolytic Thrombectomy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rheolytic Thrombectomy Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Rheolytic Thrombectomy Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Rheolytic Thrombectomy Sales Value Share by Application (2021-2026) Table 28. Global Rheolytic Thrombectomy Sales Value Share by Application (2027-2032) Table 29. Global Rheolytic Thrombectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Rheolytic Thrombectomy Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Rheolytic Thrombectomy Sales Value Share by Region (2021-2026) Table 32. Global Rheolytic Thrombectomy Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Rheolytic Thrombectomy Sales Value Share by Region (2027-2032) Table 34. Global Rheolytic Thrombectomy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Rheolytic Thrombectomy Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Rheolytic Thrombectomy Sales Value Market Share by Country (2021-2026) Table 37. Global Rheolytic Thrombectomy Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Rheolytic Thrombectomy Sales Value Market Share by Country (2027-2032) Table 39. Abbott Laboratories Company Information Table 40. Abbott Laboratories Business Overview Table 41. Abbott Laboratories Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Abbott Laboratories Rheolytic Thrombectomy Product Portfolio Table 43. Abbott Laboratories Recent Development Table 44. Koninklijke Philips N.V. Company Information Table 45. Koninklijke Philips N.V. Business Overview Table 46. Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio Table 48. Koninklijke Philips N.V. Recent Development Table 49. Terumo Corporation Company Information Table 50. Terumo Corporation Business Overview Table 51. Terumo Corporation Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Terumo Corporation Rheolytic Thrombectomy Product Portfolio Table 53. Terumo Corporation Recent Development Table 54. Boston Scientific Group Company Information Table 55. Boston Scientific Group Business Overview Table 56. Boston Scientific Group Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Boston Scientific Group Rheolytic Thrombectomy Product Portfolio Table 58. Boston Scientific Group Recent Development Table 59. Medtronic plc Company Information Table 60. Medtronic plc Business Overview Table 61. Medtronic plc Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Medtronic plc Rheolytic Thrombectomy Product Portfolio Table 63. Medtronic plc Recent Development Table 64. AngioDynamics Company Information Table 65. AngioDynamics Business Overview Table 66. AngioDynamics Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. AngioDynamics Rheolytic Thrombectomy Product Portfolio Table 68. AngioDynamics Recent Development Table 69. Penumbra Inc. Company Information Table 70. Penumbra Inc. Business Overview Table 71. Penumbra Inc. Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Penumbra Inc. Rheolytic Thrombectomy Product Portfolio Table 73. Penumbra Inc. Recent Development Table 74. Stryker Corporation Company Information Table 75. Stryker Corporation Business Overview Table 76. Stryker Corporation Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Stryker Corporation Rheolytic Thrombectomy Product Portfolio Table 78. Stryker Corporation Recent Development Table 79. Teleflex Incorporated Company Information Table 80. Teleflex Incorporated Business Overview Table 81. Teleflex Incorporated Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio Table 83. Teleflex Incorporated Recent Development Table 84. Johnson and Johnson Company Information Table 85. Johnson and Johnson Business Overview Table 86. Johnson and Johnson Rheolytic Thrombectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Johnson and Johnson Rheolytic Thrombectomy Product Portfolio Table 88. Johnson and Johnson Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Rheolytic Thrombectomy Product Image Figure 2. Global Rheolytic Thrombectomy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rheolytic Thrombectomy Market Size (2021-2032) & (US$ Million) Figure 4. Global Rheolytic Thrombectomy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Automated Devices Image Figure 8. Manual Devices Image Figure 9. Global Rheolytic Thrombectomy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Rheolytic Thrombectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Rheolytic Thrombectomy Sales Value Share by Type (2021-2032) Figure 12. Peripheral Diseases Image Figure 13. Coronary Disease Image Figure 14. Neural Diseases Image Figure 15. Global Rheolytic Thrombectomy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Rheolytic Thrombectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Rheolytic Thrombectomy Sales Value Share by Application (2021-2032) Figure 18. Global Rheolytic Thrombectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Rheolytic Thrombectomy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Rheolytic Thrombectomy Sales Value (2021-2032) & (US$ Million) Figure 21. North America Rheolytic Thrombectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Rheolytic Thrombectomy Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Rheolytic Thrombectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Rheolytic Thrombectomy Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Rheolytic Thrombectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Rheolytic Thrombectomy Sales Value (2021-2032) & (US$ Million) Figure 27. South America Rheolytic Thrombectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Rheolytic Thrombectomy Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Rheolytic Thrombectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Automated Devices
  • Manual Devices
Applications
  • Peripheral Diseases
  • Coronary Disease
  • Neural Diseases
Companies covered
  • Abbott Laboratories
  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Boston Scientific Group
  • Medtronic plc
  • AngioDynamics
  • Penumbra Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Johnson and Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rheolytic Thrombectomy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rheolytic Thrombectomy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Rheolytic Thrombectomy Market Dynamics
  1. 2.1 Rheolytic Thrombectomy Industry Trends
  2. 2.2 Rheolytic Thrombectomy Industry Drivers
  3. 2.3 Rheolytic Thrombectomy Industry Opportunities and Challenges
  4. 2.4 Rheolytic Thrombectomy Industry Restraints
3 Rheolytic Thrombectomy Market by Company
  1. 3.1 Global Rheolytic Thrombectomy Company Revenue Ranking in 2025
  2. 3.2 Global Rheolytic Thrombectomy Revenue by Company (2021-2026)
  3. 3.3 Global Rheolytic Thrombectomy Company Ranking (2024-2026)
  4. 3.4 Global Rheolytic Thrombectomy Company Manufacturing Base and Headquarters
  5. 3.5 Global Rheolytic Thrombectomy Company Product Type and Application
  6. 3.6 Global Rheolytic Thrombectomy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Rheolytic Thrombectomy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Rheolytic Thrombectomy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Rheolytic Thrombectomy Market by Type
  1. 4.1 Rheolytic Thrombectomy Type Introduction
  2. 4.1.1 Automated Devices
  3. 4.1.2 Manual Devices
  4. 4.2 Global Rheolytic Thrombectomy Sales Value by Type
  5. 4.2.1 Global Rheolytic Thrombectomy Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rheolytic Thrombectomy Sales Value by Type (2021-2032)
  7. 4.2.3 Global Rheolytic Thrombectomy Sales Value Share by Type (2021-2032)
5 Rheolytic Thrombectomy Market by Application
  1. 5.1 Rheolytic Thrombectomy Application Introduction
  2. 5.1.1 Peripheral Diseases
  3. 5.1.2 Coronary Disease
  4. 5.1.3 Neural Diseases
  5. 5.2 Global Rheolytic Thrombectomy Sales Value by Application
  6. 5.2.1 Global Rheolytic Thrombectomy Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rheolytic Thrombectomy Sales Value by Application (2021-2032)
  8. 5.2.3 Global Rheolytic Thrombectomy Sales Value Share by Application (2021-2032)
6 Rheolytic Thrombectomy Regional Value Analysis
  1. 6.1 Global Rheolytic Thrombectomy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rheolytic Thrombectomy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Rheolytic Thrombectomy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Rheolytic Thrombectomy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rheolytic Thrombectomy Sales Value (2021-2032)
  7. 6.3.2 North America Rheolytic Thrombectomy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Rheolytic Thrombectomy Sales Value (2021-2032)
  10. 6.4.2 Europe Rheolytic Thrombectomy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Rheolytic Thrombectomy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Rheolytic Thrombectomy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Rheolytic Thrombectomy Sales Value (2021-2032)
  16. 6.6.2 South America Rheolytic Thrombectomy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Rheolytic Thrombectomy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Rheolytic Thrombectomy Sales Value Share by Country, 2025 VS 2032
7 Rheolytic Thrombectomy Country-level Value Analysis
  1. 7.1 Global Rheolytic Thrombectomy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rheolytic Thrombectomy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Rheolytic Thrombectomy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Rheolytic Thrombectomy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Rheolytic Thrombectomy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Rheolytic Thrombectomy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Rheolytic Thrombectomy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Rheolytic Thrombectomy Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Koninklijke Philips N.V.
  8. 8.2.1 Koninklijke Philips N.V. Company Information
  9. 8.2.2 Koninklijke Philips N.V. Business Overview
  10. 8.2.3 Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio
  12. 8.2.5 Koninklijke Philips N.V. Recent Developments
  13. 8.3 Terumo Corporation
  14. 8.3.1 Terumo Corporation Company Information
  15. 8.3.2 Terumo Corporation Business Overview
  16. 8.3.3 Terumo Corporation Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Corporation Rheolytic Thrombectomy Product Portfolio
  18. 8.3.5 Terumo Corporation Recent Developments
  19. 8.4 Boston Scientific Group
  20. 8.4.1 Boston Scientific Group Company Information
  21. 8.4.2 Boston Scientific Group Business Overview
  22. 8.4.3 Boston Scientific Group Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Group Rheolytic Thrombectomy Product Portfolio
  24. 8.4.5 Boston Scientific Group Recent Developments
  25. 8.5 Medtronic plc
  26. 8.5.1 Medtronic plc Company Information
  27. 8.5.2 Medtronic plc Business Overview
  28. 8.5.3 Medtronic plc Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medtronic plc Rheolytic Thrombectomy Product Portfolio
  30. 8.5.5 Medtronic plc Recent Developments
  31. 8.6 AngioDynamics
  32. 8.6.1 AngioDynamics Company Information
  33. 8.6.2 AngioDynamics Business Overview
  34. 8.6.3 AngioDynamics Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AngioDynamics Rheolytic Thrombectomy Product Portfolio
  36. 8.6.5 AngioDynamics Recent Developments
  37. 8.7 Penumbra Inc.
  38. 8.7.1 Penumbra Inc. Company Information
  39. 8.7.2 Penumbra Inc. Business Overview
  40. 8.7.3 Penumbra Inc. Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Penumbra Inc. Rheolytic Thrombectomy Product Portfolio
  42. 8.7.5 Penumbra Inc. Recent Developments
  43. 8.8 Stryker Corporation
  44. 8.8.1 Stryker Corporation Company Information
  45. 8.8.2 Stryker Corporation Business Overview
  46. 8.8.3 Stryker Corporation Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Stryker Corporation Rheolytic Thrombectomy Product Portfolio
  48. 8.8.5 Stryker Corporation Recent Developments
  49. 8.9 Teleflex Incorporated
  50. 8.9.1 Teleflex Incorporated Company Information
  51. 8.9.2 Teleflex Incorporated Business Overview
  52. 8.9.3 Teleflex Incorporated Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio
  54. 8.9.5 Teleflex Incorporated Recent Developments
  55. 8.10 Johnson and Johnson
  56. 8.10.1 Johnson and Johnson Company Information
  57. 8.10.2 Johnson and Johnson Business Overview
  58. 8.10.3 Johnson and Johnson Rheolytic Thrombectomy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Johnson and Johnson Rheolytic Thrombectomy Product Portfolio
  60. 8.10.5 Johnson and Johnson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst